Stay updated with breaking news from Global Source. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Si-544 was well tolerated with no serious adverse effects, dose limiting toxicities, or safety signals observed75% of patients receiving si-544 experienced objective clinical improvement, of which 44% achieved clear or
Si-544 was well tolerated with no serious adverse effects, dose limiting toxicities, or safety signals observed75% of patients receiving si-544 ex...
BANK lending to both households and corporate borrowers could remain tepid as long as the Bangko Sentral ng Pilipinas (BSP) keeps key policy rates high, according to US-based Global Source Partners. In a brief, Global Source Partners country analyst Diwa Guinigundo said that due to the high rates, there has…
Best-in-class Kv1.3 blocker has successfully completed a Phase 1b trial in atopic dermatitis patientsPipeline molecule to treat T cell mediated autoimmune diseases
CNN is closing out 2023 as a top 5 cable network, the #1 digital news outlet, while reaching a new audience on CNN Max.